Andrea Crocker

Title: Andrea Crocker: Innovator in Immunotherapy

Introduction

Andrea Crocker is a prominent inventor based in New Hope, PA (US). She has made significant contributions to the field of immunotherapy, holding a total of four patents. Her work focuses on developing innovative therapeutic solutions that enhance immune responses.

Latest Patents

Among her latest patents are the "Agonistic antibodies that bind human CD40 and uses thereof." This patent discloses isolated monoclonal agonistic antibodies that bind to human CD40, along with related antibody-based compositions and molecules. Additionally, it outlines therapeutic and diagnostic methods for utilizing these antibodies. Another patent details methods of inducing or enhancing an immune response through the administration of agonistic anti-CD40 antibodies, further emphasizing her commitment to advancing medical science.

Career Highlights

Andrea Crocker is currently associated with Celldex Therapeutics Limited, where she continues to push the boundaries of immunotherapy research. Her innovative approaches have positioned her as a key player in the development of new therapeutic strategies.

Collaborations

Some of her notable coworkers include Tibor P Keler and Joel Goldstein, who collaborate with her in advancing their shared goals in the field of immunotherapy.

Conclusion

Andrea Crocker is a trailblazer in the realm of immunotherapy, with a strong portfolio of patents that reflect her dedication to enhancing immune responses. Her work at Celldex Therapeutics Limited and collaborations with esteemed colleagues further underscore her impact on the field.